XOMA Royalty Corp
XOMA26.740USD
-0.750-2.73%
Handelsschluss 05/14, 16:00（ET）Kurse um 15 Minuten verzögert
319.61MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über XOMA Royalty Corp Unternehmen
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), Cetrelimab (JNJ-63723283), Ersodetug (RZ358), MIPLYFFATM (arimoclomol), Acimtamig (AFM13), Ficlatuzumab (AV-299), COM902, Vosaroxin, Aldoxorubicin, MNPR-101, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, DSUVIA (sufentanil sublingual tablet), IXINITY, Vidutolimod (CMP-001), MT-0169, RZ-402, G03-52-0, AFM24, Mezagitamab (TAK-079), among others.
Unternehmensinformationen
Unternehmens-codeXOMA
Name des UnternehmensXOMA Royalty Corp
IPO-datumJun 06, 1986
Gegründet am2011
CEOMr. Owen P. Hughes, Jr.
Anzahl der mitarbeiter13
WertpapierartOrdinary Share
GeschäftsjahresendeJun 06
Addresse2200 Powell Street
StadtEMERYVILLE
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl94608
Telefon15102047239
Websitehttps://www.xoma.com/
Unternehmens-codeXOMA
IPO-datumJun 06, 1986
Gegründet am2011
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
6.46K
-48.42%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
--
-100.00%
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Mr. Owen P. Hughes, Jr.
Mr. Owen P. Hughes, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bradley J. (Brad) Sitko
Mr. Bradley J. (Brad) Sitko
Chief Investment Officer
Chief Investment Officer
--
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
6.46K
-48.42%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
--
-100.00%
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Switzerland
14.80M
51.95%
United States
12.06M
42.34%
Asia Pacific
1.13M
3.95%
Europe
500.00K
1.76%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Mon, May 5
Update-Zeit: Mon, May 5
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
BVF Partners L.P.
24.96%
Fidelity Management & Research Company LLC
8.69%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Morgan Stanley Investment Management Inc. (US)
2.45%
Other
55.96%
Aktionärsstatistik
Aktionäre
Anteil
BVF Partners L.P.
24.96%
Fidelity Management & Research Company LLC
8.69%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Morgan Stanley Investment Management Inc. (US)
2.45%
Other
55.96%
Art
Aktionäre
Anteil
Hedge Fund
29.64%
Investment Advisor
17.31%
Investment Advisor/Hedge Fund
11.96%
Individual Investor
0.80%
Research Firm
0.42%
Bank and Trust
0.07%
Pension Fund
0.03%
Insurance Company
0.02%
Other
39.75%
Institutionelle Beteiligung
Update-Zeit: Wed, Mar 5
Update-Zeit: Wed, Mar 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
148
7.24M
60.53%
-991.01K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
2023Q1
155
7.51M
65.57%
+97.45K
2022Q4
157
7.16M
62.50%
-122.23K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BVF Partners L.P.
2.98M
24.9%
-650.72K
-17.91%
Jan 24, 2025
Fidelity Management & Research Company LLC
1.04M
8.69%
-4.36K
-0.42%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
498.79K
4.16%
+6.57K
+1.33%
Dec 31, 2024
The Vanguard Group, Inc.
463.84K
3.87%
+41.45K
+9.81%
Dec 31, 2024
Morgan Stanley Investment Management Inc. (US)
292.74K
2.44%
+140.95K
+92.86%
Dec 31, 2024
Opaleye Management Inc.
250.00K
2.09%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
182.19K
1.52%
-551.00
-0.30%
Dec 31, 2024
Woodline Partners LP
156.27K
1.3%
+60.93K
+63.91%
Dec 31, 2024
State Street Global Advisors (US)
144.53K
1.21%
+1.67K
+1.17%
Dec 31, 2024
Stonepine Capital Management, LLC
125.70K
1.05%
-69.40K
-35.57%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Tue, May 6
Update-Zeit: Tue, May 6
Name
Anteil
iShares Micro-Cap ETF
0.03%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Value ETF
0%
Mehr Anzeigen
iShares Micro-Cap ETF
Anteil0.03%
ProShares Hedge Replication ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
Avantis US Equity ETF
Anteil0%
Avantis US Small Cap Equity ETF
Anteil0%
iShares Russell 2000 Value ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten